Eating Disorders News and Research

Latest Eating Disorders News and Research

Estrogen replacement therapy reduces anxiety symptoms in girls with anorexia nervosa

Estrogen replacement therapy is associated with a significant decrease in anxiety symptoms among girls with anorexia nervosa, a new clinical trial finds. The results will be presented today at The Endocrine Society's Annual Meeting in San Francisco.

18 Jun 2013

European Commission amends marketing authorisation for Celgene's REVLIMID

Celgene International Sàrl was today notified that the European Commission has amended the marketing authorisation for REVLIMID. This decision means that REVLIMID is now approved to treat patients with transfusion-dependent anaemia due to low or intermediate-1 risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate.

17 Jun 2013

Teva to present abstracts on AZILECT at MDS meeting

Teva Pharmaceutical Industries Ltd. announced today that a number of abstracts will be presented during the 17th Annual International Congress of Parkinson's Disease and Movement Disorders in Sydney, Australia, June 16-20, 2013, also known as the Movement Disorders Society.

15 Jun 2013

Brain circuits involved in compulsive behavior reveal a surprising connection with obesity

What started as an experiment to probe brain circuits involved in compulsive behavior has revealed a surprising connection with obesity.

11 Jun 2013

Altered function of neural circuitry contributes to bulimia and anorexia

Anorexia nervosa and bulimia nervosa -disorders characterized by extreme eating behavior and distorted body image - are among the deadliest of psychiatric disorders, with few proven effective treatments.

4 Jun 2013

Combination of psychotherapy with DC may improve eating disorder psychopathology, body weight

The combination of psychotherapy with dietary counseling might be a potential useful strategy to improve both eating disorder psychopathology and body weight in patients with BED.

27 May 2013

Lightlake Therapeutics announces Phase II clinical trial results of nasal spray treatment for BED

Lightlake Therapeutics Inc., a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that results of the Company's Phase II clinical trial of its nasal spray treatment for Binge Eating Disorder were presented at the American Psychiatric Association Annual Meeting in San Francisco by Professor Hannu Alho, MD, professor of addiction medicine at the University of Helsinki and Principal Investigator for the trial.

23 May 2013

Research finds number of links between dental health and overall health

If the eyes are the windows to your soul, then your mouth is the gateway to your overall health. Research has found a surprising number of links between the state of your dental health and your overall health.

23 May 2013

Study shows people with SE-AN can be treated with outpatient treatment programme

Patients with the most severe and dangerous form of chronic anorexia are more likely to make a significant improvement towards recovery and stay in therapy if traditional psychological treatments are re-focused from weight gain to quality of life issues.

20 May 2013

Researchers link coffee consumption with reduced risk of primary sclerosing cholangitis

Research presented today at Digestive Disease Week explores new discoveries in liver disease research, with findings about the impact of coffee on autoimmune disease and palliative care for cirrhotic patients.

20 May 2013

Shire's scientific data on treatments for psychiatric disorders to be presented at APA meeting

Shire plc, the global specialty biopharmaceutical company, announces that it will present scientific data in 7 poster presentations at the American Psychiatric Association 166th Annual Meeting in San Francisco, May 18-22.

20 May 2013

Neupro reduces PLMS and total NSBP elevations in patients with RLS, study finds

UCB today announced data from a double-blind, placebo-controlled study that found that Neupro (Rotigotine Transdermal System) reduced total nocturnal systolic blood pressure elevations associated with periodic limb movements during sleep and total PLMS in patients with idiopathic moderate-to-severe Restless Legs Syndrome/Willis-Ekbom disease.

18 May 2013

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Bayer HealthCare announced today that new data on the oncology portfolio, including Nexavar (sorafenib) tablets, Stivarga (regorafenib) tablets and the recently U.S. Food and Drug Administration approved product Xofigo (radium Ra 223 dichloride) injection will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology, May 31 – June 4, in Chicago, IL (USA).

16 May 2013

Springer, SISDCA partner to publish scientific journal on eating disorders and obesity

Springer and the Italian Society for the Study of Eating Disorders (Societ- Italiana per lo Studio dei Disturbi del Comportamento Alimentare - SISDCA) have agreed to a five-year collaboration to publish the quarterly journal Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, starting in 2013 with Volume 18. As the official journal of SISDCA, it will be available exclusively in electronic format on SpringerLink.

16 May 2013

Regular marijuana use is associated with favorable indices related to diabetic control, say investigators

Regular marijuana use is associated with favorable indices related to diabetic control, say investigators. They found that current marijuana users had significantly lower fasting insulin and were less likely to be insulin resistant, even after excluding patients with a diagnosis of diabetes mellitus. Their findings are reported in the current issue of The American Journal of Medicine.

15 May 2013

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Bayer HealthCare announced today that patient enrollment is underway for RESORCE (Regorafenib after Sorafenib in Patients with Hepatocellular Carcinoma), an international Phase III trial to evaluate the efficacy and safety of Stivarga (regorafenib) tablets for the treatment of patients with hepatocellular carcinoma who have progressed on Nexavar (sorafenib) tablets, an anticancer medicine for the treatment of patients with unresectable HCC.

15 May 2013

Severe anorexia nervosa improves with modification of standard goals, treatment methods

A new, multinational randomized clinical trial has found that patients with severe and enduring anorexia nervosa will not only stick with treatments but also make significant improvements with just a slight modification of the standard goals and methods of treatment.

10 May 2013

Eating Disorders News and Research

Latest Eating Disorders News and Research

Estrogen replacement therapy reduces anxiety symptoms in girls with anorexia nervosa

European Commission amends marketing authorisation for Celgene's REVLIMID

Teva to present abstracts on AZILECT at MDS meeting

Brain circuits involved in compulsive behavior reveal a surprising connection with obesity

Altered function of neural circuitry contributes to bulimia and anorexia

Combination of psychotherapy with DC may improve eating disorder psychopathology, body weight

Lightlake Therapeutics announces Phase II clinical trial results of nasal spray treatment for BED

Research finds number of links between dental health and overall health

Study shows people with SE-AN can be treated with outpatient treatment programme

Researchers link coffee consumption with reduced risk of primary sclerosing cholangitis

Shire's scientific data on treatments for psychiatric disorders to be presented at APA meeting

Neupro reduces PLMS and total NSBP elevations in patients with RLS, study finds

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Springer, SISDCA partner to publish scientific journal on eating disorders and obesity

Regular marijuana use is associated with favorable indices related to diabetic control, say investigators

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Severe anorexia nervosa improves with modification of standard goals, treatment methods

Study suggests that biology plays role in eating disorders

Biological Psychiatry special issue tackles the question on food addiction

Non-invasive brain surgery: an interview with Dr Andres Lozano, University of Toronto

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Eating Disorders News and Research

Latest Eating Disorders News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in